Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
PLx Pharma
Age
50–75
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Subject is ≥50 to ≤75 years of age.
Subject is healthy.
Subject has a BMI between 20 and 32
If female and of child bearing potential, subject has a negative pregnancy test and is not nursing.
You may not be if
Subject has abnormal screening/baseline laboratory parameters or endoscopic observations deemed clinically significant by the Investigator.
Subject has an active Helicobacter pylori infection.
Subject has a prior GI ulcer, bleeding, obstruction or perforation.
Subject has taken aspirin or any aspirin containing product within the last 4 weeks, or a non-aspirin NSAID product within 2 weeks.
Subject has taken any of the following medications within 2 weeks prior to enrollment: Any anti-platelet agents, anti-coagulants or selective serotonin reuptake inhibitors.
Subject has used an investigational agent within the past 30 days.
Subject has hypersensitivity or contraindications to aspirin, ibuprofen, or other NSAID.
Clareo Health | Endoscopic Evaluation of Upper Gastrointestinal (GI) Mucosal Damage Induced by PL-2200 Versus Aspirin in Healthy Volunteers
